Stem cell research advances signaling methods for stroke and blood cell preservation

Researchers are making advancements in stem cell therapies by focusing on signaling mechanisms rather than direct cell transplantation. In studies involving ischemic stroke, the secretome from human dental pulp stem cells (hDPSC) demonstrated potential in reducing infarct volume and attenuating neuronal apoptosis in mouse models. The secretome contains neurotrophic, antioxidant, and immunomodulatory factors that help reduce oxidative stress and inflammatory signaling while improving neurogenesis and synaptic organization.

In a separate study, researchers from the University of Zurich and the University of California, Santa Cruz, investigated ways to preserve the regenerative capacity of blood stem cells during laboratory processing. They found that the protein activated protein C (aPC) helps blood stem cells maintain a state of quiescence, or rest. This prevents the cells from differentiating prematurely, which is a common issue when using thrombin, thereby helping the cells retain the vital characteristics necessary for successful bone marrow transplantations and gene therapies.